Expression and function of a recombinant endothelial nitric oxide synthase gene in porcine coronary arteries.

[1]  Z. Katušić,et al.  Expression and function of recombinant endothelial nitric oxide synthase gene in canine basilar artery. , 1997, Circulation research.

[2]  J. Mudgett,et al.  Transcriptional regulation of human inducible nitric oxide synthase (NOS2) gene by cytokines: initial analysis of the human NOS2 promoter. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[3]  R. Wilensky,et al.  Efficient adenovirus-mediated perivascular gene transfer and protein delivery by a transvascular injection catheter , 1996 .

[4]  Y. Kaneda,et al.  Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[5]  Von der Leyen.  Gene therapy inhibiting neointimal vascular lesion , 1995 .

[6]  D. Spector,et al.  [3] Construction and isolation of recombinant adenoviruses with gene replacements , 1995 .

[7]  J. Stamler,et al.  Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation , 1994, Cell.

[8]  E. Müller‐Schweinitzer.  Arterial Smooth Muscle Function after Prolonged Exposure to a Medium Containing Dimethyl Sulfoxide (Me2SO) and Storage at -196°C , 1994 .

[9]  J. Sowers,et al.  Effects of pioglitazone on calcium channels in vascular smooth muscle. , 1994, Hypertension.

[10]  H. Schaff,et al.  Impaired endothelium-dependent relaxation after coronary reperfusion injury: evidence for G-protein dysfunction. , 1994, The Annals of thoracic surgery.

[11]  C. Nathan,et al.  Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. , 1994, The Journal of biological chemistry.

[12]  H. Schaff,et al.  Oxygen radical-mediated vascular injury selectively inhibits receptor-dependent release of nitric oxide from canine coronary arteries. , 1994, The Journal of thoracic and cardiovascular surgery.

[13]  E. Müller‐Schweinitzer.  Arterial smooth muscle function after prolonged exposure to a medium containing dimethyl sulfoxide (Me2SO) and storage at -196 degrees C. , 1994, Cryobiology.

[14]  M. Currie,et al.  A fluorometric assay for the measurement of nitrite in biological samples. , 1993, Analytical biochemistry.

[15]  J. Stamler,et al.  Nitric oxide synthase in human and rat lung: immunocytochemical and histochemical localization. , 1993, American journal of respiratory cell and molecular biology.

[16]  C. Lowenstein,et al.  Cytokines, endotoxin, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[17]  P. Tempst,et al.  Endothelial nitric oxide synthase: molecular cloning and characterization of a distinct constitutive enzyme isoform. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[18]  A. Nussler,et al.  Stimulation of the nitric oxide synthase pathway in human hepatocytes by cytokines and endotoxin , 1992, The Journal of experimental medicine.

[19]  J. Cunningham,et al.  Molecular cloning and functional expression of an inducible nitric oxide synthase from a murine macrophage cell line. , 1992, The Journal of biological chemistry.

[20]  J. Hevel,et al.  Purification of the inducible murine macrophage nitric oxide synthase. Identification as a flavoprotein. , 1991, The Journal of biological chemistry.

[21]  F. Murad,et al.  Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[22]  W. Edwards,et al.  Restenosis after balloon angioplasty. A practical proliferative model in porcine coronary arteries. , 1990, Circulation.

[23]  S. Snyder,et al.  Localization of nitric oxide synthase indicating a neural role for nitric oxide , 1990, Nature.

[24]  P. Felgner.  Particulate systems and polymers for in vitro and in vivo delivery of polynucleotides , 1990 .

[25]  H. Schaff,et al.  Acute impairment of endothelium-dependent relaxations to aggregating platelets following reperfusion injury in canine coronary arteries. , 1990, Circulation research.

[26]  S. Snyder,et al.  Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[27]  P. Vanhoutte,et al.  Flunarizine inhibits endothelium‐dependent hypoxic facilitation in canine coronary arteries through an action on vascular smooth muscle , 1988, British journal of pharmacology.

[28]  L. Ignarro,et al.  Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[29]  S. Moncada,et al.  The anti‐aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide , 1987, British journal of pharmacology.

[30]  S. Moncada,et al.  Comparative pharmacology of endothelium‐derived relaxing factor, nitric oxide and prostacyclin in platelets , 1987, British journal of pharmacology.

[31]  H. Shimokawa,et al.  Porcine coronary arteries with regenerated endothelium have a reduced endothelium-dependent responsiveness to aggregating platelets and serotonin. , 1987, Circulation research.

[32]  J. Sanes,et al.  Use of a recombinant retrovirus to study post‐implantation cell lineage in mouse embryos. , 1986, The EMBO journal.

[33]  F. Volkert,et al.  The genetic analysis of recombination using adenovirus overlapping terminal DNA fragments. , 1983, Virology.

[34]  R. Alexander,et al.  Inhibition of platelet function by organic nitrate vasodilators. , 1980, Blood.

[35]  N. Jones,et al.  Isolation of adenovirus type 5 host range deletion mutants defective for transformation of rat embryo cells , 1979, Cell.

[36]  F. Graham,et al.  Characteristics of a human cell line transformed by DNA from human adenovirus type 5. , 1977, The Journal of general virology.